Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab
出版年份 2021 全文链接
标题
Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab
作者
关键词
Chemoradiotherapy, Durvalumab, Non–small-cell lung cancer, PACIFIC, Radiation pneumonitis
出版物
Clinical Lung Cancer
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-02-06
DOI
10.1016/j.cllc.2021.01.017
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Comparison of Radiation Techniques in Patients Treated With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer
- (2020) Jonathan Peng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer
- (2020) Hiroto Inoue et al. INVESTIGATIONAL NEW DRUGS
- Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer
- (2020) Hyun Ae Jung et al. LUNG CANCER
- Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non‐small cell lung cancer: Management of adverse events
- (2020) Yu Miura et al. Thoracic Cancer
- Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab
- (2020) Narek Shaverdian et al. Cancer Medicine
- Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: CheckMate 153
- (2020) David M. Waterhouse et al. JOURNAL OF CLINICAL ONCOLOGY
- Durvalumab after definitive chemoradiotherapy in locally advanced unresectable Non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)
- (2020) Martin Faehling et al. LUNG CANCER
- Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre study
- (2020) Antoine Desilets et al. EUROPEAN JOURNAL OF CANCER
- Radiation-Induced Lung Injury
- (2019) Alexander N. Hanania et al. CHEST
- Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC
- (2019) Jhanelle E. Gray et al. Journal of Thoracic Oncology
- Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC
- (2019) Steven H. Lin et al. Journal of Thoracic Oncology
- ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer
- (2018) Ursula Nestle et al. RADIOTHERAPY AND ONCOLOGY
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
- (2018) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
- (2017) Stephen G. Chun et al. JOURNAL OF CLINICAL ONCOLOGY
- Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity
- (2017) Sandra Garcia et al. Journal of Thoracic Oncology
- Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer
- (2017) Christina K. Speirs et al. Journal of Thoracic Oncology
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2016) Suresh Senan et al. JOURNAL OF CLINICAL ONCOLOGY
- Intensity-Modulated Radiotherapy, Not 3 Dimensional Conformal, Is the Preferred Technique for Treating Locally Advanced Disease With High-Dose Radiotherapy: The Argument Against
- (2015) Allan Price SEMINARS IN RADIATION ONCOLOGY
- Nondosimetric Risk Factors for Radiation-Induced Lung Toxicity
- (2015) Feng-Ming (Spring) Kong et al. SEMINARS IN RADIATION ONCOLOGY
- Intensity-Modulated Radiotherapy, Not 3 Dimensional Conformal, Is the Preferred Technique for Treating Locally Advanced Lung Cancer
- (2015) Joe Y. Chang SEMINARS IN RADIATION ONCOLOGY
- Combined Analysis of V20, VS5, Pulmonary Fibrosis Score on Baseline Computed Tomography, and Patient Age Improves Prediction of Severe Radiation Pneumonitis After Concurrent Chemoradiotherapy for Locally Advanced Non–Small-Cell Lung Cancer
- (2014) Kayoko Tsujino et al. Journal of Thoracic Oncology
- Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
- (2013) David A. Palma et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: Predictors of use and association with toxicities
- (2013) Shervin M. Shirvani et al. LUNG CANCER
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007
- (2010) Yoshihiko Segawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105
- (2010) Nobuyuki Yamamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Influence of Technologic Advances on Outcomes in Patients With Unresectable, Locally Advanced Non–Small-Cell Lung Cancer Receiving Concomitant Chemoradiotherapy
- (2009) Zhongxing X. Liao et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Dose–volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy
- (2008) Hekun Jin et al. RADIOTHERAPY AND ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation